Antitissue antibodies in chronic pancreatitis

Area of Science:

• Immunology
• Gastroenterology
• Hepatology

Background:

• Autoantibodies (AA) are implicated in various autoimmune diseases.
• Chronic pancreatitis (CP) and liver cirrhosis (LC) are conditions with potential autoimmune components.
• Understanding AA prevalence in CP is crucial for disease characterization.

Purpose of the Study:

• To determine the prevalence of organ- and nonorgan-specific autoantibodies in patients with alcoholic or idiopathic chronic pancreatitis.
• To investigate the correlation between autoantibody presence and clinical features of chronic pancreatitis.
• To compare autoantibody profiles in chronic pancreatitis with those in liver cirrhosis.

Main Methods:

• Investigated autoantibodies (AA) in 49 patients with chronic pancreatitis (CP).
• Compared AA prevalence in CP patients with age- and sex-matched healthy controls (C) and patients with liver cirrhosis (LC).
• Utilized indirect immunofluorescence (IFL) to detect different autoantibody patterns.

Main Results:

• Autoantibodies (AA) were detected in approximately 50% of CP patients, significantly higher than in healthy controls (8%, p < 0.001).
• Distinct autoantibody profiles were observed: antibrush border, antireticulin, and antigastric parietal cell antibodies were more prevalent in CP, whereas antinuclear and antismooth muscle antibodies were more common in LC.
• No significant correlation was found between the presence of AA and clinical factors such as sex, age, etiology, pancreatic stones, diabetes, symptoms, or disease duration in CP.

Conclusions:

• The presence of autoantibodies (AA) is a frequent finding in chronic pancreatitis (CP).
• Specific autoantibody patterns differentiate CP from liver cirrhosis (LC).
• The clinical significance of autoantibodies in chronic pancreatitis remains unclear and requires further investigation.